Management of glaucoma in high myopia: Guidelines from the French Glaucoma Society (SFG) and the French-speaking Retina Specialists’ Club (CFSR)
Year: 2026
Type: article
Abstract: Glaucoma is the leading cause of irreversible blindness worldwide. High myopia, an independent risk factor for this disease, adds complexity to its diagnosis, follow-up, and medical and surgical management. These guidelines represent a consensus of French glaucoma and retina experts on the management of glaucoma in high myopia. The therapeutic strategy and follow-up modalities are similar to those used for primary open-angle glaucoma, the goal being to achieve a target intraocular pressure (IOP) that prevents the onset or worsening of glaucomatous damage. In case of elevated IOP and diagnostic uncertainty due to extensive chorioretinal alterations interfering with the fundus assessment and interpretation of tests, IOP-lowering treatment may be initiated to prevent the risk of irreversible glaucomatous damage in addition to that already associated with high myopia. The increased incidence of postoperative complications should be taken into account when considering a surgical management.
Source: Journal Français d Ophtalmologie
Institutions: Université Paris Cité, Hôpital Lariboisière, Fondation de Rothschild, CHU Dijon Bourgogne, Université Bourgogne Europe, Université Paris-Saclay, Centre hospitalier national d'ophtalmologie des Quinze-Vingts, Assistance Publique – Hôpitaux de Paris, Hôpital Ambroise-Paré, Hôpital Paris Saint-Joseph, Centre National de la Recherche Scientifique, Aix-Marseille Université, Institut de Neurosciences de la Timone, Centre Hospitalier Universitaire de Caen Normandie, Hôpital Rothschild, Fondation Ophtalmologique Adolphe de Rothschild, Centre Hospitalier Universitaire de Toulouse
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,100
OpenAlex ID: W7204261317